Estrace Articles
Stock Commentary - Europe
7 April 2003
Stock Commentary - Europe
31 March 2003
Galen gets US OK for Femring
31 March 2003
Galen's Femring cleared by FDA
31 March 2003
BioSante says gel treats menopause symptoms
10 March 2003
Update: Sales up 11% at Schering AG
10 March 2003
Galen EPS leaps 35%, beating forecasts
17 February 2003
Noven doubles incomes in 2nd qtr; Novogyne up 127%
19 August 2002
King Pharma posts 36% leap in earnings
5 August 2002
Prempro fall-out could affect Schering AG
22 July 2002
King to buy Ortho-Prefest for $108 million
13 May 2002
Novavax withdraws Estrasorb file in USA
6 May 2002
Akzo set to break record level profits
29 April 2002
Novartis launches new ERT patch in Germany
15 April 2002
Estrasorb provides menopausal relief
8 April 2002
Barr's generic Levlite OKed in USA
8 April 2002
Noven Pharma boost from JV revenues
4 March 2002
Biocompatibles to test estrogen-loaded stent
18 February 2002
Pretax profits up 25% at Novo Nordisk
18 February 2002
Pharmacia Canada has named Paladin Labs as the exclusive Canadian distributorhyperprolactinemia, Estring (estradiol vagi
28 January 2002
Pharmacia & Paladin sign Canadian distribution deal
28 January 2002
BioSante licenses rights to Combi Gel from Antares Pharma
14 January 2002
Schering AG gets French OK for new HRT product
14 January 2002
Galen submits NDA for Estrace to the FDA
7 January 2002
Galen submits NDA for Estrace to the FDA
24 December 2001
Galen sales and pretax up sharply; Menoring filing soon
14 November 2001
Pretax profits up 33% at Novo Nordisk
7 November 2001
Huge leap in net income at Duramed Pharmaceuticals
24 October 2001
New data on Galen's intravaginal ring
8 October 2001
Low-dose estrogen effective acne treatment
11 September 2001
Oral HRT products set to boom to 2010
29 August 2001
King pays $285 million for B-MS drugs
10 August 2001
Novartis files Estradot in the EU
7 August 2001
FDA raises issues on Schering AG's HRT NDA
5 July 2001
Galen buying B-MS' drug for L67 million
4 July 2001
Novavax files for Estrasorb approval in USA
3 July 2001
Schering AG's Climodien approved in EU
12 June 2001
Galen 2nd-qtr profits and revenues soar
2 May 2001
Low-dose Climara cleared in USA
11 April 2001
Galen's IVR product approved in the UK
10 April 2001
Schering AG to "grow faster than market"
16 March 2001
Tentative approval for Barr's generic contraceptive
15 March 2001
Galen's first IVR product approvable in UK for HRT
25 January 2001
Galen outlines R&D progress
24 January 2001
Oral Fludara launched in first market
22 January 2001
J&J files NDA for Ortho Evra in USA
28 December 2000
Novartis and Noven sign EstradotT deal
9 November 2000
Modernizing Merck KGaA looking to long-term growth from pharma
8 November 2000
Pharmacia gets FDA OK for once-monthly contraceptive
10 October 2000
Operating profit up 34% at Novo Nordisk
15 August 2000
Pharmacia launches Vagifem in USA
3 August 2000
Novo Nordisk and AHP settle HRT litigation
21 June 2000
Novo Nordisk and AHP settle patent dispute
16 June 2000
"Robust" 1st qtr for Novo Nordisk
5 May 2000
Pharmacia gains FDA OK for Activella
18 April 2000
Warner Chilcott acquires women's products from B-MS
28 January 2000
P&U to market Novo Nordisk's HRT drugs in USA
13 January 2000
Galen Holdings raises L37 million in placing
29 November 1999
Novartis sublicenses HRT patches from R-PR
11 October 1999
J&J developing novel contraceptive patch
22 July 1999
World's smallest HRT patch launched in USA
13 May 1999
Novo Nordisk health care sales rise 8%
19 February 1999
ESI Lederle's generic estradiol approved
21 January 1999
New Noven ERT patch
13 January 1999
Phase III for emergency contraceptive
21 December 1998
US FDA Approves Novo Nordisk's Activelle
19 November 1998
US FDA Approves Groupe Fournier's Esclim
12 November 1998
Rhone-Poulenc Rorer's Estalis Patch Approved
13 October 1998
Evolution In Migraine Therapy; New Triptans, And Beyond
10 September 1998
First Combination HRT Patch Cleared In USA
13 August 1998
Many US Companies Go Into The Black For 2nd Qtr
5 August 1998
Noven Files To Market HRT Patch In UK
9 July 1998
EU Approval For Novo's Activelle
9 July 1998
Galen And Ferring Plan L1.5 Billion Merger
24 June 1998
Merged AHP/Monsanto Will Be Top US Drugmaker
15 June 1998
Organon's Mircette Approved By FDA
23 April 1998
First Approval For New R-PR Patch
12 March 1998
Duramed Approval
2 January 1998
Strong Growth At Galen Holdings, Profits Rise 34%
17 December 1997
P&G And TheraTech: Testosterone Patches For Women
4 December 1997
US 2nd Qtr Corporate Results Round-Up
7 August 1997
R-PR Japan Submits PLA For Menorest In Japan
24 July 1997
Alora Launched In USA
30 May 1997
FDA Clears Wyeth-Ayerst's Alesse
7 April 1997
Warner-Lambert Launches Estrostep In USA
7 April 1997
Schering AG Launches New HRT Patch In UK
17 March 1997
Ortho's Low-Dose OC Cleared For Acne In USA
13 January 1997
French Generic Market "Still Weak And Patchy"
16 December 1996
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
